Metformin and repaglinide and Trastuzumab and Hyaluronidase
Determining the interaction of Metformin and repaglinide and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: metformin / repaglinide
Brand name: PrandiMet
Synonyms: Repaglinide and Metformin
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Metformin and repaglinide-Trastuzumab Injection (Intravenous)
- Metformin and repaglinide-Trastuzumab Intravenous
- Metformin and repaglinide-Trastuzumab-anns
- Metformin and repaglinide-Trastuzumab-dkst
- Metformin and repaglinide-Trastuzumab-dkst Intravenous
- Metformin and repaglinide-Trasylol
- Trastuzumab and Hyaluronidase-Metformin and saxagliptin
- Trastuzumab and Hyaluronidase-Metformin and sitagliptin
- Trastuzumab and Hyaluronidase-Metformin Extended-Release Tablets
- Trastuzumab and Hyaluronidase-Metformin Hydrochloride
- Trastuzumab and Hyaluronidase-Metformin Oral Solution
- Trastuzumab and Hyaluronidase-Metformin Tablets